Abstract
In three different endothelial cell (EC) cultures (primary human umbilical cord vein, so-called HUVEC; and immortalized cell lines HBMEC and EA-hy-926), the effects of different xenobiotics were studied in order to standardize vascular EC models for in vitro pharmacotoxicological studies. Cell characteristics were first investigated by the production and the mRNA levels of known endothelial markers in the three EC culture models. EC secretory products, tissue plasminogen activator (tPA) and von Willebrand factor (vWF), were present in the supernatant of the immortalized cell lines. The mRNA levels of vWF, tPA, platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31), and β -integrin subunit, which are involved in the control of platelet function, coagulation, and fibrinolysis as well as in cell–matrix interactions, were investigated in all EC types. For at least three parameters, cultured cells provided marked characteristics of EC phenotype, in HUVEC and in immortalized cell lines, regardless of their origin from the macro- or microcirculation. Toxicity experiments were assessed after 24 h exposure to cadmium, cyclosporin A and cisplatin by MTT assay. These experiments show nonsignificant difference in susceptibility to cyclosporin A and cadmium on HUVEC, HBMEC, and EA-hy-926. However, HBMEC, seems to be highly susceptible to cisplatin compared to HUVEC, the latter being more sensitive than EA-hy-926. For experiments conducted with cyclosporin and cadmium, cell lines could constitute an alternative material for routine cytotoxicity studies.
Similar content being viewed by others
Abbreviations
- CsA:
-
cyclosporin A
- EC:
-
endothelial cell
- FCS:
-
fetal calf serum
- HBMEC:
-
human bone marrow endothelial cell
- HUVEC:
-
human umbilical cord vein endothelial cell
- ICAM:
-
intracellular adhesion molecule
- IMDM:
-
Iscove’s Modified Dulbecco’s Medium
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- PECAM:
-
platelet endothelial cell adhesion molecule
- tPA:
-
tissue plasminogen activator
- vWF:
-
von Willebrand factor
References
Bohets HH, Nouwen EJ, De Broe ME, Dierickx PJ. Effects of f{œ}tal calf serum on cell viability, cytotoxicity and detoxification in the two kidney-derived cells lines LLC-PK1 and MDCK. Toxicol In Vitro. 1994;8(4):559–61.
Bordenave L, Baquey C, Bareille R, et al. Endothelial cell compatibility testing of three different pellethanes. J Biomed Mater Res. 1993;11:1367–81.
Bordenave L, Rémy M, Fernandez Ph, Bareille R, Chaudet B, Baquey Ch. Conduite in vitro d’une étude de biocompatibilité pour la confection d’un substitut vasculaire bioartificiel de petit calibre. ITBM-RBM. 2000;21:227–40.
Bouís D, Hospers GAP, Meijer C, Molema G, Mulder NH. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis. 2001;4:91–102.
Chappey O, Wautier MP, Boval B, Wautier JL. Endothelial cells in culture : an experimental model for study of vascular dysfunction. Cell Biol Toxicol. 1996;12:199–205.
Chi JT, Chang HY, Haraldsen G, et al. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA. 2003;100(19):10623–8.
Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing factor VIII related antigen established by hybridization. Proc Natl Acad Sci USA. 1993;80:3734–7.
Esposito C, Fornoni A, Cornacchia F, et al. Cyclosporine induces different response in human epithelial, endothelial and fibroblast cell cultures. Kidney Int. 2000;58:123–30.
Evans SM, Casatelli A, Herreros E, et al. Development of a high throughput in vitro toxicity screen predictive of high acute in~vivo toxic potential. Toxicol In Vitro. 2001;15:579–84.
Grabowski EF, Carter CA, Tsukurov O, et al. Comparison of human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function. J Pediatr Hematol Oncol. 2000;22(3):266–8.
Guillouzo A. Hépatotoxicité in vitro. In: Adolphe M, Guillouzo A, Marano F, eds. Toxicologie cellulaire in vitro: méthodes et applications. INSERM; 1995;3:33–48.
Harvey K, Welch Z, Kovala AT, Garcia JG, English D. Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin. Microvasc Res. 2002;63(3):316–26.
Jackson DE. The unfolding tale of PECAM-1. FEBS. 2003;540:7–14.
Kaji T, Ohkawara S, Inada M, Yamamoto C, Sakamoto M, Kozuka H. Cadmium stimulation of glycosaminoglycan synthesis by cultured vascular endothelial cells: comparison of various cell types. Biol Pharm Bull. 1994;17(3):454–7.
Kaji T, Suzuki M, Yamamoto C, et al. Sensitive response of cultured vascular smooth-muscle cells to cadmium cytotoxicity: comparison with cultured vascular endothelial cells and kidney epithelial LLC-PK1 cells. Toxicol Lett. 1996;89:131–97.
Kohn S, Fradis M, Podoshin L, Ben David J, Zidan J, Robinson E. Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin. Ultrastruct Pathol. 1997;21(3):289–99.
Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001;194(6):F37–42.
Lang I, Hoffmann C, Olip H, et al. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif. 2001;34:143–55.
Lau DCW, Wong KL, Hwang WS. Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int. 1989;35(2):604–13.
L’Azou B, Dubus I, Ohayon-Courtès C, et al. Cadmium induced direct morphological changes in mesangial cell culture. Toxicology. 2002;179(3):233–45.
Marin V, Kaplanski G, Grès S, Farnarier C, Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods. 2001;254:183–90.
Markovic S, Raab M, Daxecker H, Griesmacher A, Karimi A, Muller MM. In vitro effects of cyclosporin A on the expression of adhesion molecules on human umbilical vein endothelial cells. Clin Chim Acta. 2002;316:25–31.
Marshall NJ, Goodwin CJ, Holt SJ. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 1995;5(2):69–84.
Moldovan F, Soliman HR, Bennani H, et al. Functional properties of a new line of immortalized human endothelial cell. CR Acad Sci III. 1995;318(9):951–8.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic asays. J Immunol Methods. 1983;65:55–63.
Moussa SA. Expression of adhesion molecules during cadmium hepatotoxicity. Life Sci. 2004;75(1):93–105.
Muller AM, Hermanns MI, Skrzynski C, Nesslinger M, Muller KM, Kirkpatrick CJ. Expression of the endothelial markers PECAM-1, vWf and CD34 in vivo and in vitro. Exp Mol Pathol. 2002;72:221–9.
Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1. New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol. 2003; 23: 953–64.
Niwa A, Suzuki A. Effects of cadmium on the tension of isolated rat aorta–-a possible mechanism for cadmium-induced hypertension. J Toxicol Sci. 1982;7(1):51–60.
Nolan CV, Shaikh ZA. The vascular endothelium as a target tissue in acute cadmium toxicity. Life Sci. 1986;39(16):1403–9.
Nuver J, Smit AJ, Sleijfer DT, et al. Micralbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer. 2004;40(5):701–6.
Pruis J, Emeis JJ. Endothelin-1 and -3 induce release of tissue-type plasminogen activator and von Willebrand factor from endothelial cells. Eur J Pharmacol. 1990;187(1):105–12.
Revis NW, Zinsmeister AR, Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci USA. 1981;78(10): 6494–8.
Ruegg C, Mariotti A. Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci. 2003;60:1135–57.
Schweitzer KM, Vicart P, Delouis C, et al. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest. 1997;76:25–36.
Scoumanne A, Kalamati T, Moss J, Powell JT, Gosling M, Carey N. Generation and characterisation of human saphenous vein endothelial cell lines. Atherosclerosis. 2002;160:59–67.
Szuster-Ciesielska A, Lokaj I, Kandefer-Szerszen M. The influence of cadmium and zinc ions on the interferon and tumor necrosis factor production in bovine aorta endothelial cells. Toxicology. 2000;145:135–45.
Wagner M, Hermanns I, Bittinger F, Kirkpatrick CJ. Induction of stress proteins in human endothelial cells by heavy metal ions and heat shock. Am J Physiol. 1999;277(21):L1026–33.
Woywodyt A, Schoeder M, Mengel M, et al. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension. 2003;41(3):720–23.
Yoshikawa A, Saura R, Matsubara T, Mizuno K. A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization. Kobe J Med Sci. 1997;43(3/4):109–20.
Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986;55:455–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
L’Azou, B., Fernandez, P., Bareille, R. et al. In vitro endothelial cell susceptibility to xenobiotics: Comparison of three cell types. Cell Biol Toxicol 21, 127–137 (2005). https://doi.org/10.1007/s10565-005-0172-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10565-005-0172-8